Thoracic radiotherapy synergizes with first-line EGFR-TKIs in advanced EGFR-mutant NSCLC: A dual-center real-world study.
Sign Up to like & getrecommendations! Published in 2025 at "International journal of cancer"
DOI: 10.1002/ijc.70243
Abstract: First-line thoracic radiotherapy (TRT) with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) shows promising efficacy in advanced EGFR-mutated non-small-cell lung cancer (NSCLC), yet clinical evidence remains limited. This dual-center retrospective study evaluated 322 patients receiving… read more here.
Keywords: generation; trt; progression; tki trt ... See more keywords